Needham & Company LLC Weighs in on Teleflex FY2025 Earnings

Teleflex Incorporated (NYSE:TFX) – Analysts at Needham & Company LLC dropped their FY2025 earnings estimates for shares of Teleflex in a report issued on Tuesday, January 27th. Needham & Company LLC analyst M. Matson now expects that the medical technology company will post earnings per share of $13.96 for the year, down from their previous forecast of $14.11. Needham & Company LLC has a “Buy” rating and a $138.00 price objective on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share.

Other equities research analysts also recently issued research reports about the stock. Truist Financial lifted their price target on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research note on Thursday, December 18th. Wall Street Zen lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Wells Fargo & Company decreased their price objective on Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a report on Thursday. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research note on Monday, December 29th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $135.00 target price on shares of Teleflex in a report on Wednesday, December 17th. Two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $139.00.

Teleflex Price Performance

Shares of NYSE:TFX opened at $104.40 on Friday. The firm has a market capitalization of $4.61 billion, a PE ratio of -14.20, a PEG ratio of 1.38 and a beta of 0.93. The company has a current ratio of 2.57, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. Teleflex has a 1-year low of $100.18 and a 1-year high of $184.34. The business’s 50 day moving average is $116.10 and its 200-day moving average is $119.56.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The business had revenue of $892.90 million during the quarter, compared to analyst estimates of $892.79 million. During the same quarter in the prior year, the business earned $3.49 earnings per share. The firm’s revenue for the quarter was up 19.4% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend was Friday, November 14th. Teleflex’s payout ratio is currently -18.50%.

Institutional Investors Weigh In On Teleflex

A number of hedge funds have recently added to or reduced their stakes in TFX. AQR Capital Management LLC raised its stake in shares of Teleflex by 478.1% in the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after acquiring an additional 1,956,811 shares during the last quarter. Abrams Bison Investments LLC acquired a new stake in shares of Teleflex in the third quarter valued at approximately $112,317,000. Norges Bank acquired a new stake in shares of Teleflex in the second quarter valued at approximately $65,826,000. Thrivent Financial for Lutherans raised its position in Teleflex by 1,161.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 550,449 shares of the medical technology company’s stock worth $67,353,000 after purchasing an additional 506,796 shares during the last quarter. Finally, Capital International Investors acquired a new position in Teleflex during the 3rd quarter worth $44,851,000. Institutional investors own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.